1. Home
  2. FHB vs EWTX Comparison

FHB vs EWTX Comparison

Compare FHB & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Hawaiian Inc.

FHB

First Hawaiian Inc.

HOLD

Current Price

$25.75

Market Cap

3.4B

Sector

Finance

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$41.98

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FHB
EWTX
Founded
1858
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
FHB
EWTX
Price
$25.75
$41.98
Analyst Decision
Sell
Buy
Analyst Count
7
6
Target Price
$27.00
$39.00
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
04-24-2026
05-07-2026
Dividend Yield
3.86%
N/A
EPS Growth
22.91
N/A
EPS
1.15
N/A
Revenue
$880,788,000.00
N/A
Revenue This Year
$7.00
N/A
Revenue Next Year
$3.56
N/A
P/E Ratio
$21.96
N/A
Revenue Growth
8.94
N/A
52 Week Low
$22.65
$13.69
52 Week High
$30.58
$48.40

Technical Indicators

Market Signals
Indicator
FHB
EWTX
Relative Strength Index (RSI) 34.49 46.10
Support Level $24.98 $37.50
Resistance Level $27.74 $45.48
Average True Range (ATR) 0.46 2.13
MACD -0.08 -0.44
Stochastic Oscillator 20.07 19.92

Price Performance

Historical Comparison
FHB
EWTX

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: